Brief: Entrada Therapeutics - On Oct 26 Co, Vertex Pharmaceuticals Entered Amendment No. 1 To Strategic Collaboration & License Agreement, Dated Dec 7, 2022

Entrada Therapeutics

01/11/2023 11:22

Nov 1 (Reuters) - Entrada Therapeutics Inc  TRDA.O :
    * ENTRADA THERAPEUTICS- ON OCT 26 CO, VERTEX PHARMACEUTICALS
ENTERED AMENDMENT NO. 1 TO STRATEGIC COLLABORATION & LICENSE
AGREEMENT, DATED DEC 7, 2022
    * ENTRADA THERAPEUTICS INC-  IN CONNECTION WITH ENTRY INTO
AND
UNDER TERMS OF LICENSE AGREEMENT, COMPANY RECEIVED AN UPFRONT
PAYMENT OF $223.7 MILLION
    * ENTRADA THERAPEUTICS INC- AMENDMENT TO LICENSE AGREEMENT
AND
AMENDMENT TO SUBLICENSE AGREEMENT EACH CLARIFY A MILESTONE AND
RELATED PAYMENT TERMS

Further company coverage:  TRDA.O 

 ((Reuters.briefs@thomsonreuters.com;))